WKW December 13, 2022 Brilacidin Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis
WKW May 27, 2021 Brilacidin Patient Enrollment Reaches 90 Percent in Innovation Pharma’s Phase 2 Clinical Trial of Brilacidin for COVID-19
WKW April 28, 2021 Brilacidin Innovation Pharma Surpasses 50 Percent Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19
WKW April 14, 2021 Brilacidin Innovation Pharma’s Broad Spectrum Antiviral Drug Candidate Brilacidin Highlighted in Biodefense and Infectious Diseases COVID-19 Presentation
WKW April 5, 2021 Brilacidin Innovation Pharma Completes Interim Safety Data Review—DMC Approves Increased Dosing Frequency in Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients
